miR-181a promotes G1/S transition and cell proliferation in pediatric acute myeloid leukemia by targeting ATM.

作者: Xiaodan Liu , Wang Liao , Hongxia Peng , Xuequn Luo , Ziyan Luo

DOI: 10.1007/S00432-015-1995-1

关键词:

摘要: Abnormal expression of miRNAs is intimately related to a variety human cancers. The purpose this study confirm the miR-181a and elucidate its physiological function mechanism in pediatric acute myeloid leukemia (AML). Pediatric AML patients healthy controls were enrolled, ataxia telangiectasia mutated (ATM) tissues examined using quantitative PCR. Moreover, cell proliferation cycle evaluated several lines (HL60, NB4 K562) by flow cytometry after transfected with mimics inhibitors, or ATM siRNA control siRNA. Finally, as potential target protein was examined. We found that significantly increased AML, which showed an inverse association expression. Overexpressed enhanced proliferation, well ratio S-phase cells transfection vitro. Luciferase activity reporter construct identified direct molecular miR-181a. results revealed novel through regulates G1/S transition regulating tumor suppressor ATM, providing insights into AML.

参考文章(36)
Aurora Esquela-Kerscher, Frank J. Slack, Oncomirs — microRNAs with a role in cancer Nature Reviews Cancer. ,vol. 6, pp. 259- 269 ,(2006) , 10.1038/NRC1840
Michael B. Kastan, Dae-sik Lim, The many substrates and functions of ATM. Nature Reviews Molecular Cell Biology. ,vol. 1, pp. 179- 186 ,(2000) , 10.1038/35043058
Michael B. Kastan, Jiri Bartek, Cell-cycle checkpoints and cancer Nature. ,vol. 432, pp. 316- 323 ,(2004) , 10.1038/NATURE03097
L K Zhuang, G P Xu, X R Pan, Y J Lou, Q P Zou, D Xia, W W Yan, Y T Zhang, P M Jia, J H Tong, MicroRNA-181a-mediated downregulation of AC9 protein decreases intracellular cAMP level and inhibits ATRA-induced APL cell differentiation. Cell Death and Disease. ,vol. 5, ,(2014) , 10.1038/CDDIS.2014.130
Guido Marcucci, Michael D. Radmacher, Kati Maharry, Krzysztof Mrózek, Amy S. Ruppert, Peter Paschka, Tamara Vukosavljevic, Susan P. Whitman, Claudia D. Baldus, Christian Langer, Chang-Gong Liu, Andrew J. Carroll, Bayard L. Powell, Ramiro Garzon, Carlo M. Croce, Jonathan E. Kolitz, Michael A. Caligiuri, Richard A. Larson, Clara D. Bloomfield, MicroRNA expression in cytogenetically normal acute myeloid leukemia The New England Journal of Medicine. ,vol. 358, pp. 1919- 1928 ,(2008) , 10.1056/NEJMOA074256
Chang-Zheng Chen, MicroRNAs as Oncogenes and Tumor Suppressors The New England Journal of Medicine. ,vol. 353, pp. 1768- 1771 ,(2005) , 10.1056/NEJMP058190
Haitao Bai, Zhongwei Cao, Chong Deng, Lili Zhou, Chun Wang, miR-181a sensitizes resistant leukaemia HL-60/Ara-C cells to Ara-C by inducing apoptosis Journal of Cancer Research and Clinical Oncology. ,vol. 138, pp. 595- 602 ,(2012) , 10.1007/S00432-011-1137-3
Yi-Bing Ouyang, Yu Lu, Sibiao Yue, Rona G. Giffard, miR-181 targets multiple Bcl-2 family members and influences apoptosis and mitochondrial function in astrocytes. Mitochondrion. ,vol. 12, pp. 213- 219 ,(2012) , 10.1016/J.MITO.2011.09.001
Lei Shi, Zihao Cheng, Junxia Zhang, Rui Li, Peng Zhao, Zhen Fu, Yongping You, hsa-mir-181a and hsa-mir-181b function as tumor suppressors in human glioma cells. Brain Research. ,vol. 1236, pp. 185- 193 ,(2008) , 10.1016/J.BRAINRES.2008.07.085